{"data":{"id":"us/28-cfr-79.36","jurisdiction":"us","citation":"28 CFR 79.36","heading":"Indication of the presence of hepatitis B or cirrhosis.","body":"Possible indication of hepatitis B or cirrhosis will be determined in accordance with the provisions of § 79.27.","path":["Title 28—Judicial Administration","CHAPTER I—DEPARTMENT OF JUSTICE","PART 79—CLAIMS UNDER THE RADIATION EXPOSURE COMPENSATION ACT","Subpart D—Eligibility Criteria for Claims by Onsite Participants"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-28.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:25:14Z","sha256":"92032abbf541d308a8ee4d6c45c7421a1830a9b05c415950ea8325c02785311c","source_id":"us-cfr","stale":true,"prev":"us/28-cfr-79.35","next":"us/28-cfr-79.40"},"notice":"GroundRules: Original legal text. Not legal advice."}
